Literature DB >> 2786575

Infertility in a man with 21-hydroxylase deficient congenital adrenal hyperplasia.

H A Mirsky1, J H Hines.   

Abstract

Congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency in men can cause profound oligospermia. The mechanism for this condition is overproduction of adrenal androgens, which in turn inhibit gonadotropin secretion. Men with a mild subclinical form of congenital adrenal hyperplasia may remain undiagnosed until adulthood. We report on a man who presented with infertility secondary to profound oligospermia. The treatment of this condition resulted in improved semen quality and subsequent conception. The importance of family history and determining whether precocious puberty was present, as well as obtaining appropriate laboratory tests is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786575     DOI: 10.1016/s0022-5347(17)38677-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.

Authors:  D Merke; M Kabbani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Reversible male infertility in late onset congenital adrenal hyperplasia.

Authors:  A Augarten; R Weissenberg; C Pariente; J Sack
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

3.  Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review.

Authors:  Y Sugino; T Usui; K Okubo; K Nagahama; T Takahashi; H Okuno; H Hatayama; O Ogawa; A Shimatsu; H Nishiyama
Journal:  J Assist Reprod Genet       Date:  2006-10-11       Impact factor: 3.412

4.  Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.

Authors:  Oskar Ragnarsson; Gudmundur Johannsson; Kjell Geterud; Par Lodding; Per Dahlqvist
Journal:  BMJ Case Rep       Date:  2013-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.